10x Genomics, Inc. is trading at $28.81 (-5.82%) in pre-market as the stock pulls back from a rally driven by its recent acquisition announcement.
- The decline follows a sharp surge in the prior session linked to the company's deal to acquire Proteintech Genomics.
- Market sentiment is cooling as the stock eases from gains tied to the M&A news, with investors likely taking profits.
- No additional company-specific catalysts were reported overnight to sustain the previous session's upward momentum.